drugset / Trial / NCT00702442
Role of Droperidol in Postoperative Vomiting
Phase 4
Completed
100 enrolled
Aristotle University Of Thessaloniki
AHEPA University Hospital · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Protocol title: Role of low dose droperidol in postoperative vomiting Purpose: Evaluate the efficacy of droperidol to postoperative nausea and vomiting when administrated at the introduction to anesthesia, prior to surgery Design: Prospective, randomized, placebo-controlled study Patient Population: Male or female subjects 18 years of age or older who are scheduled for laparoscopic cholecystectomy No. of Subjects: 100 patients divided into two groups, estimated up to 6 months to enroll Duration of Treatment: Prior operation Duration of Follow-up: Follow-up will be performed for 24 hours postoperatively Endpoints: To evaluate the effectiveness of low dose droperidol when administered Prior surgery
Timeline
- Start
- 2008-06
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Droperidol | Small molecule | 0.625 mg | Intravenous |
Indications
No indication recorded.